Sanofi India has launched its diabetes drug Soliqua in India, a once-daily injectable combination drug containing insulin and ...

Soliqua is indicated as treatment in adults with obesity and type 2 diabetes mellitus, to improve glycemic control as an ...

Soliqua is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting basal ...

Sanofi reported that in India, over 100 million individuals are grappling with type 2 diabetes and its associated ...

Sanofi India launches Soliqua, a once-daily injectable diabetes drug, in the country. The medication costs Rs 1,850 per pen and is indicated for adults with type 2 diabetes who are poorly controlled ...

an anti-inflammatory and insulin-sensitizer that permeates the blood brain barrier, could represent a novel oral treatment targeting an underlying cause of long COVID symptoms CARSON CITY, Nev., April ...

The injectable combination is aimed at helping adults with obesity and type 2 diabetes mellitus better manage their blood ...

Hair loss is a slow burn, and you might not realize your hair is thinning until a small bald patch begins to appear on your ...

FitSpresso emerged as a noteworthy alternative to Liraglutide, championing natural ingredients scientifically proven to ...

Koyuncu, MD, have no significant financial interests to disclose. Kuscu NK, Koyuncu FM. Insulin and Oral Antidiabetic Agents for Treatment of Polycystic Ovary Syndrome. MedGenMed 4(4), 2002 ...